Drugmakers Assail FDA For Nixing Generic Laxative Approval
Two drugmakers are attacking the U.S. Food and Drug Administration for rescinding approvals of generic versions of a Bayer AG laxative, warning of higher costs and "serious medical ramifications" for patients....To view the full article, register now.
Already a subscriber? Click here to view full article